Publicis acquires Google's Performics

Share this article:
Publicis Groupe has announced the acquisition of Performics, a Google search marketing business. The transaction is expected to be completed by the end of the third quarter.

Performics will be integrated into Publicis's VivaKi Nerve Center, a strategic entity that was launched last June. VivaKi Nerve Center leverages Digitas, Starcom-MediaVest, Denuo and Zenith-Optimedia to “develop new services, tools and partnerships, including new and emerging performance marketing platforms,” according to a company statement.

“The acquisition of Performics will position the Groupe for significant growth by delivering a broad portfolio of clients into our operations,” said Maurice Levy, chairman and CEO of Publicis, in the statement. “Not only will this acquisition bring critical mass to Publicis Groupe's formidable search capabilities, but it will also enhance our affiliate marketing and overall performance marketing offering.”
Headquartered in Chicago and employing almost 200 “search marketing specialists,” Performics also has employees in San Francisco, New York, London, Hamburg, Sydney, Singapore and Beijing. Performics executives will report to Curt Hecht, president of VivaKi Nerve Center, according to the statement. 

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?